Ticker League

SELLAS Life Sciences Group (SLS) Free Cash Flow Bridge

Pinpoint what moved SELLAS Life Sciences Group's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

TTM

FCF YoY

+16.45%

OCF YoY

+16.45%

Capex Change

+0.0

FCF Conversion Δ

Free cash flow bridge for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $5.55M

FCF bridge breakdown for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow−$33.71M
  • Operating Cash Flow$5.55M
  • Capital Expenditure$0.00
  • Free Cash Outflow−$28.16M
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation